Open AccessClinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting
Author(s) -
Motoyasu Kato,
Shinichi Sasaki,
Misa Tateyama,
Yuta Arai,
Hiroaki Motomura,
Issei Sumiyoshi,
Yusuke Ochi,
Junko Watanabe,
Hiroaki Ihara,
Shinsaku Togo,
Kazuhisa Takahashi
Publication year - 2021
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s284819
Subject(s) - nintedanib , tolerability , medicine , nausea , idiopathic pulmonary fibrosis , adverse effect , anorexia , gastroenterology , lung